Societal monetary benefits of pharmaceutical innovation: the case of ramipril in Canada.
Objectives: To estimate the monetary benefits of ramipril and its distribution over time among four beneficiaries in Canada: the drug developing manufacturer, generic manufacturers, the healthcare sector and employment sectors.